BlackRock’s Pharvaris PHVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.7M Buy
771,454
+14,241
+2% +$431K ﹤0.01% 3077
2026
Q1
$21.4M Buy
757,213
+48,655
+7% +$1.3M ﹤0.01% 3045
2025
Q4
$19.7M Buy
708,558
+294,141
+71% +$7.08M ﹤0.01% 3117
2025
Q3
$10.3M Buy
414,417
+213,328
+106% +$4.73M ﹤0.01% 3439
2025
Q2
$3.54M Buy
201,089
+8,224
+4% +$133K ﹤0.01% 3901
2025
Q1
$3.03M Sell
192,865
-1,330
-0.7% -$22.4K ﹤0.01% 3857
2024
Q4
$3.72M Sell
194,195
-1,153
-0.6% -$23.7K ﹤0.01% 3842
2024
Q3
$3.62M Buy
195,348
+193,080
+8,513% +$3.53M ﹤0.01% 3825
2024
Q2
$42.6K Hold
2,268
﹤0.01% 4896
2024
Q1
$52.4K Hold
2,268
﹤0.01% 4860
2023
Q4
$63.6K Hold
2,268
﹤0.01% 4921
2023
Q3
$47.3K Buy
2,268
+2,112
+1,354% +$38.9K ﹤0.01% 5015
2023
Q2
$2.36K Hold
156
﹤0.01% 5362
2023
Q1
$1.26K Hold
156
﹤0.01% 5463
2022
Q4
$1.75K Hold
156
﹤0.01% 5612
2022
Q3
$1K Buy
+156
New +$2.44K ﹤0.01% 5756
2021
Q3
Sell
-33,382
Closed -$622K 5680
2021
Q2
$622K Hold
33,382
﹤0.01% 4638
2021
Q1
$934K Buy
+33,382
New +$1.05M ﹤0.01% 4513

Other funds holding PHVS

BlackRock's PHVS Position: Q2 2026 in Review

BlackRock increased its Pharvaris (PHVS) stake by 1.9% in Q2 2026, buying an estimated $431K and bringing the position to 771,454 shares worth $26.7M. The position accounts for ﹤0.01% of the portfolio, ranked #3077.

BlackRock first reported a position in PHVS in Q1 2021 and has held it in 18 quarters since. 23 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • BlackRock held 771,454 shares of Pharvaris worth $26.7M as of Q2 2026.
  • BlackRock bought 14,241 Pharvaris shares in Q2 2026, an estimated $431K.
  • Pharvaris made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #3077 holding.
  • BlackRock first reported a position in Pharvaris in Q1 2021 and has held it in 18 quarters since.
  • 23 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.